ImmuneRegen® Appoints Renowned Hematologist Ivan N. Rich, Ph.D. to Advisory Board ImmuneRegen(R) and BioCure Collaborate on Novel Wound-Healing Product ImmuneRegen Releases Results from UMDNJ Study Confirming Homspera's Adult Stem Cell Activity ImmuneRegen® BioSciences Signs Material Transfer Agreement with University of Medicine and Dentistry of New Jersey
|
We are excited to share with you that Immuneregen Biosciences has been nominated by the Vaccine Industry Excellence Awards as the Best Vaccine Start-up Company. This nomination adds to all of the great progress we have been making as a company and reconfirms our impact in the industry.
for job opportunities, |
